Design of universal Ebola virus vaccine candidates
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
17 Oct 2023
17 Oct 2023
Historique:
pubmed:
31
10
2023
medline:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
Ebola virus causes hemorrhagic fever in humans and poses a significant threat to global public health. Although two viral vector vaccines have been approved to prevent Ebola virus disease, they are distributed in the limited ring vaccination setting and only indicated for prevention of infection from
Identifiants
pubmed: 37904982
doi: 10.1101/2023.10.14.562364
pmc: PMC10614775
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
COMPETING INTERESTS D.X., A.E.P. and P.S.K. are named as inventors on a patent application applied for by Stanford University and the Chan Zuckerberg Biohub on immunogenic ebolavirus fusion proteins and related methods. A.E.P. is an employee of, and P.S.K. is a co-founder and member of the Board of Directors of Vaccine Company, Inc. N.J.S. is a named inventor for filovirus vaccines. All other authors declare no competing interests.
Références
N Engl J Med. 2020 May 7;382(19):1832-1842
pubmed: 32441897
Cell. 2017 May 18;169(5):878-890.e15
pubmed: 28525755
Nat Commun. 2023 Apr 17;14(1):2149
pubmed: 37069151
PLoS Pathog. 2021 Dec 9;17(12):e1010078
pubmed: 34882741
Nat Rev Microbiol. 2009 May;7(5):393-400
pubmed: 19369954
Nat Med. 2015 Sep;21(9):1065-70
pubmed: 26301691
Lancet. 2019 Mar 2;393(10174):936-948
pubmed: 30777297
Viruses. 2020 May 06;12(5):
pubmed: 32384820
PLoS One. 2016 Sep 13;11(9):e0162446
pubmed: 27622456
J Mol Biol. 2004 Dec 3;344(4):1051-69
pubmed: 15544812
J Infect Dis. 2013 Aug 1;208(3):418-22
pubmed: 23633407
Immunity. 2022 May 10;55(5):738-748
pubmed: 35545026
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
ACS Nano. 2019 Oct 22;13(10):11087-11096
pubmed: 31497947
Nature. 2014 Oct 2;514(7520):47-53
pubmed: 25171469
Annu Rev Microbiol. 2018 Sep 08;72:423-446
pubmed: 30200851
Curr Infect Dis Rep. 2015 May;17(5):480
pubmed: 25896751
J Infect Dis. 2011 Nov;204 Suppl 3:S825-32
pubmed: 21987758
BMC Med. 2023 Apr 13;21(1):144
pubmed: 37055861
Cell. 2021 Mar 4;184(5):1188-1200.e19
pubmed: 33577765
Hum Vaccin Immunother. 2018;14(9):2107-2113
pubmed: 29757706
Immunity. 2020 Sep 15;53(3):548-563.e8
pubmed: 32857950
Vaccine. 2018 May 24;36(22):3090-3100
pubmed: 28216187
Nature. 2011 Aug 24;477(7364):344-8
pubmed: 21866101
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
J Mol Biol. 2009 Jul 3;390(1):83-98
pubmed: 19427319
ACS Cent Sci. 2021 Jan 27;7(1):183-199
pubmed: 33527087
J Virol. 2014 Dec;88(24):14002-16
pubmed: 25253346
Cell. 2016 Jan 14;164(1-2):258-268
pubmed: 26771495
PLoS Pathog. 2010 May 20;6(5):e1000904
pubmed: 20502688
Sci Rep. 2018 Jul 25;8(1):11193
pubmed: 30046140
Cell. 2016 Jan 28;164(3):392-405
pubmed: 26806128
PLoS One. 2012;7(6):e39075
pubmed: 22720032
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1080-5
pubmed: 22247289
N Engl J Med. 2016 Apr 28;374(17):1647-60
pubmed: 25830326
Nat Commun. 2021 May 11;12(1):2633
pubmed: 33976149
Nat Rev Dis Primers. 2020 Feb 20;6(1):13
pubmed: 32080199
Immunity. 2018 Aug 21;49(2):301-311.e5
pubmed: 30076101
Cell Rep. 2016 May 17;15(7):1514-1526
pubmed: 27160900
Emerg Infect Dis. 2016 Jan;22(1):105-8
pubmed: 26691346
J Virol. 2006 Apr;80(8):4174-8
pubmed: 16571833
Science. 2005 Jun 10;308(5728):1643-5
pubmed: 15831716
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
N Engl J Med. 2016 Oct 13;375(15):1448-1456
pubmed: 27732819
J Virol. 2012 Jan;86(1):364-72
pubmed: 22031933
Nature. 2008 Jul 10;454(7201):177-82
pubmed: 18615077
J Virol. 2018 Jan 17;92(3):
pubmed: 29142131
Vaccines (Basel). 2020 May 21;8(2):
pubmed: 32455764
J Infect Dis. 2018 Nov 22;218(suppl_5):S612-S626
pubmed: 29860496
Protein Sci. 1999 Apr;8(4):921-9
pubmed: 10211839
Cell Rep. 2018 Aug 14;24(7):1802-1815.e5
pubmed: 30110637
Lancet Infect Dis. 2017 Aug;17(8):854-866
pubmed: 28606591
Nat Med. 2013 Dec;19(12):1597-608
pubmed: 24309663
PLoS One. 2014 Mar 26;9(3):e92822
pubmed: 24671139
J Immunol. 2006 Jan 15;176(2):1203-8
pubmed: 16394010
Lancet Microbe. 2023 Mar;4(3):e171-e178
pubmed: 36739878
J Virol. 2003 May;77(10):5889-901
pubmed: 12719582
Front Immunol. 2022 Aug 24;13:942897
pubmed: 36091016
Nature. 2013 Jul 4;499(7456):102-6
pubmed: 23698367
PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2600
pubmed: 24367715
BMJ Glob Health. 2022 Dec;7(12):
pubmed: 36585031
Nat Immunol. 2018 Nov;19(11):1169-1178
pubmed: 30333617
Nature. 2016 Jul 7;535(7610):169-172
pubmed: 27362232
Future Virol. 2009;4(6):621-635
pubmed: 20198110
Science. 2016 Mar 18;351(6279):1339-42
pubmed: 26917593
Science. 2016 Mar 18;351(6279):1343-6
pubmed: 26917592
Cell. 2017 May 18;169(5):891-904.e15
pubmed: 28525756
J Virol. 2021 Feb 3;95(8):
pubmed: 33536172
J Virol. 2014 Jan;88(1):699-704
pubmed: 24155380
Retrovirology. 2015 Sep 26;12:82
pubmed: 26410741
N Engl J Med. 2017 Jan 26;376(4):330-341
pubmed: 25830322
Nat Microbiol. 2018 Jun;3(6):670-677
pubmed: 29736037
Nat Commun. 2016 Jun 28;7:12041
pubmed: 27349934
Vaccine. 2016 Apr 7;34(16):1927-35
pubmed: 26921779